Business
Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum
Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\nTORONTO, ON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has entered into a Letter of Intent to acquire an interest or participate in the development of a casino and hotel resort in Europe. The project will consist of 538 Hotel Rooms & VIP Suites, 5 Restaurants & Food Court, a Convention Centre, a Shopping Mall, Showroom, Nightclub, Health Spa Facility, a 1,000 Slot Machines and 50 Table Game Casino, and a 504 Car Covered Parking Garage.\n As part of the Company’s plan to enter more lucrative market segments, Easton has entered into a Letter of Intent with the US based gaming arm of a Canadian holding and investment company, to participate in the development of a casino and hotel resort property in Europe. The revenues are expected to be in excess of 77 Million Euro per year. “This casino and hotel resort project will be a high-end development in anidyllicriver location and will be the second Casino Hotel Resort Easton intends to participate in as part of our global expansion plan. It is expected to be one of the most prominent properties when it opens. I am excited for the prospects of having Easton participate in such an incredible opportunity,” stated Mr. Evan Karras. Mr. Karras further commented, “This Agreement is one of several that Easton is entering into for gaming globally and will bring the Company and its shareholders tremendous value and growth.”  Easton is currently negotiating its participation in the project and will provide assistance with the development, management and financing of the project. The property offers substantial upside, both in the gaming sector, as well as the hospitality sector. The negotiations are anticipated to be completed within the next 30 days with additional detailed information to be provided in the coming weeks or as it becomes readily available and approved for release. About Easton Pharmaceuticals Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various c...